Knowledge and Awareness Among Patients with Chronic Kidney Disease Stage 3

Identification: nnj_nd_16A5
Issue: November-December 2016
Volume: Vol. 43, No. 6
Credits (Post Test or Evaluation Required)
Available until 12/31/2018
  • 1.30 - contact hours

$30.00


Description

Contact hours available until 12/31/2018.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Nephrology Nursing Journal Editorial Board Statements of Disclosure:
In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.

Paula Dutka MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.

Norma J. Gomez, MBA, MSN, CNNe, disclosed that she is a member of the ZS Pharma Advisory Council.

Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a Fresenius employee, and freelance editor for Lippincott, Williams & Wilkins and Elsevier publishing companies.

All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.

This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Sally Russell, MN, CMSRN, CPP ANNA Education Director.

American Nephrology Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.

Learning Outcome:
After completing this learning activity, the learner will be able to describe CKD knowledge levels and awareness among patients who have CKD Stage 3 with coexisting diabetes and hypertension.

Author(s)

Credits Available


Knowledge and Awareness Among Patients with Chronic Kidney Disease Stage 3

You must be logged in and own this product in order to post comments.